Dictionnaire français - anglais

général - eur-lex.europa.eu
The tumor targeted superantigen abr-217620 selectively engages trbv7-9 and exploits tcr-pmhc affinity mimicry in mediating t cell cytotoxicity.... The conceptual objective for developing the tumor targeted superantigen (TTS) ABR-217620 (naptumomab estafenatox, 5T4Fab-SEA/E-120), now in phase 3 studies for advanced renal cell cancer, was to selectively coat tumor cells with cytotoxic T lymphocytes (CTL) target...
général - core.ac.uk - PDF: doaj.org
Antibody-based therapeutics to watch in 2011... In alphanumeric order, the 2011 therapeutic antibodies to watch list comprises AIN-457, bapineuzumab, brentuximab vedotin, briakinumab, dalotuzumab, epratuzumab, farletuzumab, girentuximab (WX-G250), naptumomab estafenatox, necitumumab, obinutuzumab, otelixizumab, pagibaximab, pertuzumab, ramucirumab, REGN88, reslizumab, solanezumab, T1h, teplizumab, trastuzumab emtansine,...
Dose finding with escalation with overdose control (ewoc) in cancer clinical trials... In particular, we show in therecently completed ABR-217620 (naptumomab estafenatox) trial that omitting animportant predictor of toxicity when dose assignments to cancer patients aredetermined results in a high percent of patients experiencing...
A randomized phase ii/iii study of naptumomab estafenatox + ifnα versus ifnα in renal cell carcinoma: final analysis with baseline biomarker subgroup and trend analysisPurpose: To prospectively determine the efficacy of naptumomab estafenatox (Nap) þ IFNa versus IFN in metastatic renal cell carcinoma (RCC).Experimental...


1 milliard de traductions classées par domaine d'activité en 28 langues